Document is current

Any future updates will be listed below

Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates

Crossref DOI link: https://doi.org/10.1038/s41419-024-07182-8

Published Online: 2024-11-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark